RÉSUMÉ
The aims of this investigation were to: 1) determine the effect of a moderately high dose of carnosine on muscle concentrations of carnosine, histidine and vitamin E at deficient, minimally adequate and sufficient levels of dietary vitamin E and 2) compare the effects of moderately high and pharmacological doses of carnosine on muscle concentrations of carnosine, histidine and vitamin E when dietary vitamin E is minimally adequate. Muscle concentrations of carnosine, histidine and vitamin E were measured in the lateral gastrocnemius and red and white vastus lateralis; carnosine and histidine concentrations were also measured in soleus muscle. Male Sprague-Dawley rats (n = 12/group) were fed a basal vitamin E-deficient diet supplemented with either 0, 0.001 or 0.01% vitamin E and 0, 0.1 or 1.8% carnosine. After 8 wk, 1.8% carnosine resulted in significant fivefold increases in carnosine and twofold increases in histidine in the soleus muscle (P < or = 0.05). Muscle vitamin E concentrations were not significantly affected by dietary carnosine. Thus, very high levels of dietary carnosine are associated with increases in carnosine and histidine concentrations in rat soleus muscle.
Sujet(s)
Carnosine/pharmacologie , Histidine/analyse , Muscles squelettiques/composition chimique , Vitamine E/analyse , Animaux , Antioxydants/analyse , Antioxydants/métabolisme , Carnosine/administration et posologie , Carnosine/analyse , Relation dose-effet des médicaments , Histidine/métabolisme , Mâle , Fibres musculaires à contraction rapide/composition chimique , Fibres musculaires à contraction rapide/métabolisme , Fibres musculaires à contraction lente/composition chimique , Fibres musculaires à contraction lente/métabolisme , Muscles squelettiques/métabolisme , Répartition aléatoire , Rats , Rat Sprague-Dawley , Vitamine E/métabolisme , Carence en vitamine E/complicationsRÉSUMÉ
OBJECTIVE: To determine effects of dietary lipid and protein on development of hepatic lipidosis (HL) and on physical and biochemical indices following rapid weight loss in cats. ANIMALS: 24 ovariohysterectomized cats. PROCEDURE: Cats were fed a high energy diet until they gained 30% of their ideal body weight and then randomly assigned to receive 1 of 4 weight-reduction diets (6 cats/diet) at 25% of maintenance energy requirements per day. Diets contained a low or high quality protein source and a lipid source deficient or sufficient in long chain essential fatty acids (LCEFA). Serum and plasma samples and liver biopsy specimens were obtained for biochemical analyses and determination of hepatic lipid content before and after weight gain and during and after weight loss. RESULTS: Irrespective of weight-reduction diet fed, all cats lost weight at a comparable rate (4.51 to 5.00 g/d/kg of obese body weight). Three cats developed hepatic lipidosis. Significant changes in plasma insulin, cholesterol, triglyceride, and serum glucose concentrations were detected after weight gain and weight loss in all diet groups, but values for these variables did not differ among groups. CONCLUSIONS AND CLINICAL RELEVANCE: Cats can lose 25 to 30% of their obese body weight over 7 to 9 weeks without developing overt clinical signs of HL, provided that weight-reduction diets are highly palatable, contain a high quality protein, have a source of LCEFA, and are fortified with vitamins and microminerals. However, rapid weight loss may increase risk factors associated with development of diabetes mellitus.
Sujet(s)
Maladies des chats/diétothérapie , Matières grasses alimentaires/pharmacologie , Protéines alimentaires/pharmacologie , Stéatose hépatique/médecine vétérinaire , Obésité/médecine vétérinaire , Perte de poids , Phénomènes physiologiques nutritionnels chez l'animal , Animaux , Analyse chimique du sang/médecine vétérinaire , Glycémie/analyse , Poids , Maladies des chats/prévention et contrôle , Chats , Cholestérol/sang , Matières grasses alimentaires/métabolisme , Protéines alimentaires/métabolisme , Acides gras indispensables/métabolisme , Acides gras indispensables/pharmacologie , Stéatose hépatique/prévention et contrôle , Femelle , Hystérectomie/médecine vétérinaire , Insuline/sang , Lipides/analyse , Foie/composition chimique , Foie/anatomopathologie , Microscopie électronique/médecine vétérinaire , Obésité/diétothérapie , Ovariectomie/médecine vétérinaire , Répartition aléatoire , Triglycéride/sangRÉSUMÉ
To determine the effect of extending the duration of ammonia (2% dry matter basis) treatment from 1 to 5 wk on the toxicity of endophyte-infected tall fescue seed, 60 male Harlan Sprague-Dawley rats were randomly assigned to the following six treatments during a 28-d trial: endophyte-free (E-), endophyte-infected (E+), 1 wk ammoniated endophyte-free (1AE-), 1 wk ammoniated endophyte-infected (1AE+), 5 wk ammoniated endophyte-free (5AE-), and 5 wk ammoniated endophyte-infected (5AE+) tall fescue seed. The concentration of total pyrrolizidine alkaloids (N-acetyl and N-formyl loline) of E+ fescue was reduced from 4203 micrograms/g to 3009 and 2533 micrograms/g by the 1AE+ and 5AE+ treatments, respectively. Ergovaline was lowered from 3.77 to 1.57 micrograms/g by 1AE+ and eliminated by 5AE+. Endophyte-infected treatment groups had depressed (P < 0.0001) daily feed intakes (DFI), daily weight gains (DWG), feed efficiencies (G/F), primary antibody responses, and T cell and B cell mitogenic responses than endophyte-free treatment groups. Ammoniation of endophyte-infected fescue seed improved DFI and DWG (P < 0.0001) and G/F (P < 0.05); however, there was no difference in performance criteria between the 1-wk and 5-wk ammoniation treatments. Endophyte-induced depressions in immune function were not alleviated by ammoniation.
Sujet(s)
Acremonium/pathogénicité , Ammoniac/pharmacologie , Intoxication par les plantes/prévention et contrôle , Poaceae/microbiologie , Graines/microbiologie , Animaux , Production d'anticorps/effets des médicaments et des substances chimiques , Poids/effets des médicaments et des substances chimiques , Activation des lymphocytes/effets des médicaments et des substances chimiques , Mâle , Taille d'organe/effets des médicaments et des substances chimiques , Alcaloïdes de type pyrrolizidine/analyse , Rats , Rat Sprague-Dawley , Rate/effets des médicaments et des substances chimiques , Rate/anatomopathologieRÉSUMÉ
To determine the effect of extending the duration of ammonia (2% dry matter basis) treatment ti'om 1 to 5 wk on the toxicity of endophyte-infected tall fescue seed, 60 male Harlan Sprague-Dawley rats were randomly assigned to the following six treatments during a 28-d trial: endophyte-free (E-), endophyte-infected (E+), 1 wk ammoniated endophyte-fee (1AE-), 1 wk ammoniated endophyte-infected (1AE+), 5 wk ammoniated endophyte-free (5AE-), and 5 wk ammoniated endophyte-infected (5AE+) tall fescue seed. The concentration of total pyrrolizidine alkaloids (N-acetyl and N-formyl loline) or E+ rescue was reduced from 4203 12 g/g to 3009 and 2533 I-tg/g by the 1AE+ and 5AE+ treatments, respectively. Ergovaline was lowered from 3.77 to 1.57 12 g/g by 1AE+ and eliminated by 5AE+. Endophyte-infected treatment groups had depressed (P < 0.0001) dally feed intakes (DFI), daily weight gains (DWG), feed efficiencies (G/F), primary antibody responses, and T cell and B cell mitogenic responses than endophyte-free treatment groups. Ammoniation of endophyte-infected rescue seed improved DFI and DWG (P < 0.0001) and G/F (P < 0.05); however, there was no difference in performance criteria between the 1-wk and 5-wk ammoniation treatments. Endophyte-induced depressions in immune function were not alleviated by ammoniation.
Sujet(s)
Acremonium/pathogénicité , Ammoniac/pharmacologie , Intoxication par les plantes/prévention et contrôle , Poaceae/microbiologie , Graines/microbiologie , Animaux , Poids , Tests d'hémagglutination , Activation des lymphocytes , Mâle , Taille d'organe , Alcaloïdes de type pyrrolizidine/analyse , Rats , Rat Sprague-Dawley , Graines/composition chimique , Ovis , Rate/anatomopathologieRÉSUMÉ
OBJECTIVE: This study was designed to determine the effect of diets enriched with plant and animal fats on oxidative stress and glutathione metabolism in rabbit liver tissues. This study was conducted to investigate whether the type of dietary fat will impact fatty acid composition and oxidant/antioxidant status in tissues. METHODS: Rabbits were fed diets containing 2 g corn oil/100 g diet (low fat diet, LF) and LF supplemented with 16 g/100 g diet of either corn oil (CO), CO with added cholesterol (CO + C), milk fat (MF), chicken fat (CF), beef tallow (BT), or lard (L) for 30 days. After the feeding period, livers were analyzed for total fatty acid composition, thiobarbituric acid reactive substances (TBARS), conjugated dienes, and reduced glutathione (GSH), as well as for activities of glutathione peroxidase (GP) and glutathione reductase (GR). Moreover, to fully determine the oxidative stability and free radical trapping capacity, TBARS levels were measured after additional exposure of liver homogenates to 10 mM 2,2(1)-azo-bis-amidinopropane- hydrochloride (AAPH) for up to 21 hours. RESULTS: CO and CF, but not saturated fats such as MF, increased liver conjugated diene and TBARS levels and decreased liver GSH levels and GP activity. In tissues additionally exposed to AAPH, the maximum oxidation, measured as TBARS, was reached between 6 and 7 hours of treatment, independent of dietary fat. In addition, there was a marked effect of AAPH on the maximum rate of TBARS formation with the following descending order: CO > CF > CO + C > L > MF > BT > LF. This high susceptibility to oxidative stress in liver tissues of rabbits fed the CO diet may be explained in part by the significant elevation in linoleic acid (18:2n-6). DISCUSSION: There appears to be an inverse correlation between dietary fat-mediated oxidative stress and antioxidant enzyme activities. The present data suggest that high levels of dietary unsaturated fat should be avoided if oxidative stress is a critical issue in nutrition-related diseases. In addition, these data support our hypothesis that diets rich in MF provide a lipid environment with low susceptibility to oxidative stress.
Sujet(s)
Matières grasses alimentaires/métabolisme , Glutathion/métabolisme , Foie/métabolisme , Stress oxydatif/physiologie , Amidines/pharmacologie , Animaux , Antioxydants/analyse , Bovins , Poulets , Cholestérol alimentaire , Huile de maïs/métabolisme , Matières grasses , Acides gras/analyse , Glutathion/analyse , Glutathione peroxidase/analyse , Glutathione peroxidase/métabolisme , Glutathione reductase/analyse , Glutathione reductase/métabolisme , Peroxydation lipidique , Foie/composition chimique , Foie/effets des médicaments et des substances chimiques , Foie/enzymologie , Mâle , Lapins , Substances réactives à l'acide thiobarbiturique/analyseRÉSUMÉ
Compared to cholesterol or linoleic acid (18:2), oxidized lipids such as cholestan-3 beta, 5 alpha, 6 beta-triol (triol) and hydroperoxy linoleic acid (HPODE) markedly impair endothelial barrier function in culture [Hennig and Boissonneault, 1987; Hennig et al. 1986]. Because proteoglycans contribute to vascular permeability properties, the effects of cholesterol and 18:2 and their oxidation products, triol and HPODE, on endothelial proteoglycan metabolism were determined. While cholesterol was without effect, a concentration-dependent decrease in cellular proteoglycans (measured by 35S incorporation) was observed after exposure to triol. Compared to control cultures, cholesterol reduced mRNA levels for the proteoglycans, perlecan and biglycan. Triol had a similar effect on biglycan but not an perlecan mRNA levels. Compared to 18:2, 1,3 and 5 microM HPODE depressed cellular proteoglycans. Perlecan mRNA levels were reduced more by HPODE when compared to 18:2. Biglycan mRNA levels were reduced by 3 microM, but not by 5 microM HPODE. These data demonstrate that oxidized lipids such as triol and HPODE can decrease cellular proteoglycan metabolism in endothelial monolayers and alter mRNA levels of major specific proteoglycans in a concentration-dependent manner. This may have implications in lipid-mediated disruption of endothelial barrier function and atherosclerosis.
Sujet(s)
Cholestanols/pharmacologie , Cholestérol/pharmacologie , Endothélium vasculaire/effets des médicaments et des substances chimiques , Protéoglycanes à sulfate d'héparane , Acides linoléiques/pharmacologie , Protéoglycanes/métabolisme , Artère pulmonaire/cytologie , Animaux , Biglycane , Perméabilité capillaire/effets des médicaments et des substances chimiques , Cellules cultivées , Endothélium vasculaire/métabolisme , Protéines de la matrice extracellulaire , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Héparitine sulfate/biosynthèse , Héparitine sulfate/génétique , Acide linoléique , Peroxydation lipidique/effets des médicaments et des substances chimiques , Oxydoréduction , Stress oxydatif , Protéoglycanes/biosynthèse , Protéoglycanes/génétique , ARN messager/biosynthèse , ARN messager/génétique , SuidaeRÉSUMÉ
Endothelial cell dysfunction is considered to be a critical event in the etiology of atherosclerosis. Thus, the preservation of endothelial structure and function are a prerequisite for normal control of vascular permeability properties, mediation of both inflammatory and immunologic responses and the general 'communication' between blood-borne cells and abluminal tissues. Many of these properties can be influenced by proteoglycans present in vascular tissues. There is evidence that selected lipids can be atherogenic by altering endothelial proteoglycan metabolism. Little is known about the role of fatty acids in modulating proteoglycan composition in endothelial cells. Data suggest, however, that linoleic acid in particular can adversely alter proteoglycan metabolism, which may be related to an imbalance in eicosanoid synthesis patterns. These events could be sufficient to disrupt normal endothelial barrier function, initiate smooth muscle migration and proliferation, and result in other metabolic dysfunctions associated with the etiology of vascular diseases such as atherosclerosis. Thus, the focus of this review is on fatty acids and eicosanoids as they may alter proteoglycan metabolism of vascular tissues and in particular of the endothelium.
Sujet(s)
Éicosanoïdes/physiologie , Endothélium vasculaire/métabolisme , Acides gras/physiologie , Protéoglycanes/physiologie , Animaux , Artériosclérose/étiologie , Cytokines/physiologie , HumainsRÉSUMÉ
Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function. To test this hypothesis, rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet (low fat diet) or low fat supplemented with 16 g/100 g diet of corn oil, corn oil with added cholesterol, milk fat, chicken fat, beef tallow or lard. Compared with those fed the low fat, serum and LDL cholesterol concentrations were significantly lower in rabbits fed corn oil and greater in animals fed corn oil with added cholesterol or chicken fat. In contrast to the cholesterol data, lipid hydroperoxide levels were highest in oxidized LDL derived from rabbits fed corn oil or lard. LDL vitamin E levels were highest in rabbits fed corn oil with added cholesterol. The significant elevations in linoleic acid [18:2(n-6)] in serum and LDL may partially explain the high oxidizability of LDL in rabbits fed corn oil. LDL isolated from animals fed corn oil, lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group. Their oxidative modification further contributed to endothelial barrier dysfunction. Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL-mediated endothelial cell dysfunction as compared with the corn oil diet group. These data suggest that beef tallow and chicken fat are the least atherogenic fats if oxidative modification of LDL is a critical issue in atherosclerosis.
Sujet(s)
Cholestérol/pharmacologie , Matières grasses alimentaires/pharmacologie , Lipoprotéines LDL/métabolisme , Animaux , Cellules cultivées , Cholestérol/métabolisme , Huile de maïs/administration et posologie , Huile de maïs/pharmacologie , Matières grasses alimentaires/administration et posologie , Endothélium/effets des médicaments et des substances chimiques , Endothélium/physiologie , Acides gras/sang , Lipoprotéines LDL/effets des médicaments et des substances chimiques , Lipoprotéines LDL/physiologie , Mâle , Oxydoréduction/effets des médicaments et des substances chimiques , Lapins , Suidae , Vitamine E/sangRÉSUMÉ
The purpose of this study was to examine the influence of oxidized low-density lipoprotein (oxLDL) on endothelial regrowth in an in vitro wounding model and the possible protection afforded by vitamin E (E). Endothelial cells grown on micropore filters were wounded by scraping and allowed to reestablish growth on denuded areas in the presence of LDL or oxLDL (25-200 micrograms/ml), linoleic acid (FA, 90 microM) or linoleic acid hydroperoxide (OFA, 15 microM) for 24 h. Some monolayers were pretreated with 25 microM E for 24 h. Transendothelial albumin movement was used as a measure of endothelial barrier function and as an indicator of endothelial monolayer regrowth. Exposure to levels of oxLDL as low as 25 micrograms/ml for 24 h resulted in depressed endothelial monolayer regrowth, whereas native LDL was without effect and pre-enrichment with 25 microM E offered no protection. In comparison, E pre-enrichment improved endothelial regrowth to control levels in FA- and OFA-treated cultures, unlike oxLDL-treated cultures. It is concluded that circulating oxLDL may reduce regrowth of wounded endothelium and supplemental E may not offer protection. Moreover, fatty acids or their hydroperoxides are unlikely to be involved in this effect.
Sujet(s)
Endothélium vasculaire/traumatismes , Lipoprotéines LDL/pharmacologie , Vitamine E/pharmacologie , Cicatrisation de plaie/effets des médicaments et des substances chimiques , Animaux , Cellules cultivées , ADN/biosynthèse , Endothélium vasculaire/métabolisme , Acide linoléique , Acides linoléiques/pharmacologie , Peroxydes lipidiques/pharmacologie , Oxydoréduction , Sérumalbumine/métabolisme , SuidaeRÉSUMÉ
The objective of this study was to investigate food restriction-related changes in several indices of immune competence in young (11 wk old) and adult (33 wk old) female lean (+/?) and obese (ob/ob) C57BL/6J mice. Body weight accumulation, tail length accretion and organ weights were more severely curtailed by food restriction in obese mice than in lean mice. Tail collagen denaturation time increased with age, although the magnitude was greater in obese mice, and this change was minimized by food restriction. Splenocyte mitogen responses were generally not altered with age in lean or obese mice, whereas food restriction augmented these responses in lean mice while having no effect or reducing them in obese mice. The concanavalin A and phytohemagglutinin responses of splenocytes from young and adult obese mice were greater than those for lean mice, whereas the bacterial lipopolysaccharide response was elevated only in adult obese vs. lean mice. Flow cytometric analysis of splenocytes revealed an increase in Thy-1+ cells with food restriction vs. freely fed obese and lean mice, with a proportional decrease in Ig+ cells. Percentages of CD4+ and CD8+ cells increased with food restriction in both lean and obese mice. These results suggest that genetic obesity largely eliminates the immunopotentiating effects of food restriction, although the rate of "aging" may be reduced by food restriction.
Sujet(s)
Privation alimentaire/physiologie , Immunocompétence , Obésité/immunologie , Vieillissement/immunologie , Animaux , Poids , Consommation alimentaire/physiologie , Femelle , Cytométrie en flux , Coeur/anatomie et histologie , Immunité cellulaire , Rein/anatomie et histologie , Numération des leucocytes , Foie/anatomie et histologie , Activation des lymphocytes , Sous-populations de lymphocytes , Souris , Souris de lignée C57BL , Souris obèse , Taille d'organe , Rate/anatomie et histologie , Rate/cytologie , Rate/immunologie , Thymus (glande)/anatomie et histologieRÉSUMÉ
The effect of dietary carnosine supplementation on plasma and tissue carnosine and alpha-tocopherol concentrations and on the formation of thiobarbituric acid reactive substances (TBARS) in rat skeletal muscle homogenates was evaluated. Plasma, heart, liver and hind leg muscle was obtained from rats fed basal semipurified diets or basal diets containing carnosine (0.0875%), alpha-tocopheryl acetate (50 ppm), or carnosine (0.0875%) plus alpha-tocopheryl acetate (50 ppm). Dietary carnosine supplementation did not increase carnosine concentrations in heart, liver and skeletal muscle. Dietary supplementation with both carnosine and alpha-tocopherol increased carnosine concentrations in liver 1.56, 1.51- and 1.51-fold as compared with diets lacking carnosine, alpha-tocopherol or both carnosine and alpha-tocopherol, respectively. Dietary supplementation with both carnosine and alpha-tocopherol also increased alpha-tocopherol concentrations in heart and liver 1-38-fold and 1.68-fold, respectively, as compared to supplementation with alpha-tocopherol alone. Dietary supplementation with carnosine, alpha-tocopherol or both carnosine and alpha-tocopherol was effective in decreasing the formation of TBARS in rat skeletal muscle homogenate, with dietary alpha-tocopherol and alpha-tocopherol plus carnosine being more effective than dietary carnosine alone. The data suggest that dietary supplementation with carnosine and alpha-tocopherol modulates some tissue carnosine and alpha-tocopherol concentrations and the formation of TBARS in rat skeletal muscle homogenates.
Sujet(s)
Antioxydants/analyse , Carnosine/pharmacologie , Muscles squelettiques/métabolisme , Vitamine E/pharmacologie , Animaux , Ansérine/analyse , Ansérine/sang , Antioxydants/pharmacologie , Carnosine/analyse , Carnosine/sang , Régime alimentaire , Histidine/analyse , Histidine/sang , Foie/métabolisme , Myocarde/métabolisme , Rats , Substances réactives à l'acide thiobarbiturique/analyse , Vitamine E/analyse , Vitamine E/sangRÉSUMÉ
The purpose of this study was to evaluate the effect of the traditional Chinese medicine Fu-Fang-Tai-Pan-Pian on responsiveness of mouse spleen leukocytes to the mitogens concanavalin A (con A), phytohemagglutinin (PHA), and bacterial endotoxin (LPS). Aqueous and chloroform/methanol extracts of the drug were prepared and added to mitogen-stimulated cultures at doses ranging from 0.625% to 20% by volume. The aqueous extract depressed responsiveness to all mitogens at all doses tested, and was significantly more potent in this regard than the organic extract. The organic extract depressed responsiveness at low dilutions; however it significantly stimulated responsiveness to PHA and LPS, but not to con A, at dilutions of 2.5% or less. The relative ability of compounds partitioning into aqueous and organic extracts of the medicinal mixture to both stimulate and depress the ability of lymphocytes to proliferate may provide insight into the mechanism of action of this and related medicines.
Sujet(s)
Médicaments issus de plantes chinoises/pharmacologie , Lymphocytes/effets des médicaments et des substances chimiques , Rate/effets des médicaments et des substances chimiques , Analyse de variance , Animaux , Cellules cultivées , Chloroforme/composition chimique , Concanavaline A/pharmacologie , Relation dose-effet des médicaments , Interactions médicamenteuses , Lipopolysaccharides/pharmacologie , Activation des lymphocytes/effets des médicaments et des substances chimiques , Lymphocytes/immunologie , Méthanol/composition chimique , Souris , Souris de lignée C57BL , Phytohémagglutinine/pharmacologie , Rate/cytologieRÉSUMÉ
Certain fatty acids induce changes in endothelial barrier function which may be mediated by alterations in normal proteoglycan synthesis/metabolism. To test this hypothesis, pulmonary artery derived endothelial cells were treated with media supplemented with linoleic acid (18:2), and/or a known proteoglycan synthesis inhibitor, beta-D-xyloside. Independent exposure to 1 mM beta-D-xyloside or 90 microM 18:2 increased albumin transfer, i.e., decreased barrier function, when compared with control cultures. 18:2 and beta-D-xyloside increased albumin transfer additively, suggesting that the mechanisms by which 18:2 and beta-D-xyloside alter the proteoglycan metabolism are different. Compared with the control group, treatment with 18:2 inhibited proteoglycan synthesis, decreased anionic properties of heparan sulfate proteoglycans in the cell monolayers and caused the release of a unique chondroitin sulfate proteoglycan into the culture media. Treatment with beta-D-xyloside caused an increased incorporation of radioactive sulfate into glycosaminoglycans but inhibited proteoglycan synthesis. These results suggest that the fatty acid- and beta-D-xyloside-induced impairment in endothelial barrier function may involve changes in the synthesis, release and physicochemical properties of proteoglycans.
Sujet(s)
Endothélium vasculaire/métabolisme , Acides linoléiques/pharmacologie , Protéoglycanes/métabolisme , Artère pulmonaire/métabolisme , Albumines/métabolisme , Animaux , Transport biologique , Cellules cultivées , Chromatographie d'échange d'ions , Diméthylsulfoxyde/pharmacologie , Relation dose-effet des médicaments , Hétérosides/pharmacologie , Acide linoléique , SuidaeRÉSUMÉ
Endothelial cell integrity has been suggested to play a role in the development of atherosclerosis. The effects of fatty acids on endothelial barrier function were tested by measuring albumin transport across endothelial monolayers cultured on polycarbonate filters. Compared with control cultures, a 24-h exposure to 90 mumol/L lauric (12:0) and linoleic acid (18:2) but not to butyric (4:0), hexanoic (6:0), octanoic (8:0), decanoic (10:0), myristic (14:0), palmitic (16:0) or stearic acid (18:0) caused an increase in albumin transfer across endothelial monolayers. Selective enrichment of a "physiological" serum fatty acid mixture (FA-Mix; 90 mumol/L) with 90 mumol/L of 12:0 or 18:2 significantly increased albumin transfer, whereas enrichment with 90 mumol/L of 4:0, 16:0 or 18:0 significantly decreased albumin transfer relative to 180 mumol/L FA-Mix. Only 12:0- or 18:2-treated cultures showed increased Ca(++)-ATPase activity and the presence of lipid droplets. Fatty acids (60 mumol/L) extracted from butter fat and beef tallow had no effect on albumin transfer, whereas fatty acids extracted from chicken fat and corn oil consistently disrupted endothelial barrier function. This fat-induced disruption of endothelial barrier function seems to be related to the amount of 18:2 present in each fat source. These data indicate that unsaturated fats cause cellular perturbations that result in a decrease in endothelial barrier function in this model system, and that high dietary levels of unsaturated fats may be detrimental to cell integrity.
Sujet(s)
Endothélium vasculaire/effets des médicaments et des substances chimiques , Acides gras insaturés/pharmacologie , Acides gras/pharmacologie , Extraits de plantes/pharmacologie , Albumines/métabolisme , Animaux , Calcium-Transporting ATPases/métabolisme , Bovins , Membrane cellulaire/effets des médicaments et des substances chimiques , Membrane cellulaire/métabolisme , Cellules cultivées , Poulets , Endothélium vasculaire/enzymologie , Endothélium vasculaire/métabolisme , SuidaeRÉSUMÉ
Cholesterol oxidation products (oxysterols), such as cholestan-3 beta,5 alpha,6 beta-triol (Triol), may be atherogenic by altering the barrier function of the vascular endothelium. We have shown that incubation of endothelial cell monolayers with Triol increased transendothelial albumin transfer (i.e., decreased barrier function) in a concentration- and time-dependent manner. Such dysfunction of endothelium could result from alterations in membrane characteristics, including changes in membrane-associated enzyme activities. To test this hypothesis, endothelial monolayers were treated with 20 microM Triol and the activities of selected membrane enzymes were measured at 0, 2, 4, 6, 12 and 24 hours. Calcium-adenosine triphosphatase (Ca(++)-ATPase) and sodium, potassium, magnesium-adenosine triphosphatase (Na+, K+, Mg(++)-ATPase) activities were significantly increased after 4 or 2 hours incubation with 20 microM Triol, respectively. 5'-nucleotidase activity was significantly elevated only after a 24-hour exposure to Triol, whereas there was no change in angiotensin-converting enzyme (ACE) activity in response to 20 microM Triol treatment at any time studied. Compared with all concentrations tested 40 microM Triol increased Ca(++)-ATPase activity most markedly, with a significant increase already after a 2-hour exposure. No major morphological changes were noted until 12 hours of exposure to 20 microM Triol; obvious cellular damage was observed by 24 hours. Cultures treated with Triol for 24 hours showed significant signs of toxicity, measured by an elevated [3H]adenine release, compared with control cultures. These data demonstrate that Triol alters the activity of certain membrane-bound enzymes, particularly Na+, K+, Mg(++)-ATPase and Ca(++)-ATPase.(ABSTRACT TRUNCATED AT 250 WORDS)
Sujet(s)
Cholestanols/pharmacologie , Endothélium vasculaire/effets des médicaments et des substances chimiques , Adénine/analyse , Albumines/métabolisme , Animaux , Cellules cultivées , Relation dose-effet des médicaments , Endothélium vasculaire/enzymologie , Endothélium vasculaire/anatomopathologie , Peptidyl-Dipeptidase A/analyse , Artère pulmonaire/cytologie , Suidae , TritiumRÉSUMÉ
A spectrum of cholesterol oxidation derivatives (oxysterols) is generated in food products exposed to heat or radiation in the presence of oxygen. One of these derivatives (cholestan-3 beta,5 alpha,6 beta-triol) was shown to compromise the selective barrier function of cultured vascular endothelial cell monolayers, an action that may initiate atherosclerotic lesion formation. This study sought to investigate the relationship of cholesterol synthesis inhibition by several naturally occurring oxysterols to depression of vascular endothelial cell monolayer barrier function, determined as an increase in albumin transfer across cultured endothelial monolayers. All oxysterols tested caused a variable time- and dose-dependent elevation in trans-endothelial albumin transfer, and they were also able to inhibit cholesterol biosynthesis to varying degrees. Pure cholesterol was without effect on both counts. The correlation between the increase in albumin transfer related to oxysterol exposure and the ability of oxysterols to suppress cholesterol biosynthesis was, however, poor. Moreover, mevinolin, a water-soluble competitive inhibitor of cholesterol synthesis, reduced the rate of cholesterol synthesis to 0.9% of control but did not significantly increase albumin transfer. Cholestan-3 beta,5 alpha,6 beta-triol caused a 660% elevation in albumin transfer while cholesterol synthesis remained at 11% of control. We conclude that changes in endothelial barrier function caused by exposure to the oxysterols examined, but not pure cholesterol, are probably related to factors other than the well-known action of cholesterol biosynthesis inhibition. These findings may have implications in the development of atherosclerosis.
Sujet(s)
Cholestanes/pharmacologie , Cholestérol/biosynthèse , Endothélium/physiologie , Animaux , Transport biologique , Perméabilité des membranes cellulaires/effets des médicaments et des substances chimiques , Cholestanols/pharmacologie , Cholestérol/analogues et dérivés , Cholestérol/pharmacologie , Déhydrocholestérols/pharmacologie , Modèles animaux de maladie humaine , Relation dose-effet des médicaments , Hydroxycholestérols/pharmacologie , Hypolipémiants/pharmacologie , Techniques in vitro , Cétocholestérols/pharmacologie , Lovastatine/pharmacologie , Sérumalbumine/pharmacocinétique , Suidae , Facteurs tempsRÉSUMÉ
High levels of plasma low-density lipoproteins (LDL) are known to be a risk factor for developing coronary artery disease although the specific mechanism involved is unknown. It may be related to effects of oxidized lipid components of LDL on vascular endothelial barrier function (EBF). This study addressed the hypothesis that LDL-associated products of cholesterol oxidation, oxysterols, decrease EBF resulting in increased penetration of blood components such as LDL into the arterial wall. LDL from human volunteers and rabbits was enriched with cholesterol or cholestan-3 beta,5 alpha,6 beta triol (Triol) by in vitro incubation. Exposure of cultured vascular endothelial cell monolayers to LDL enriched with Triol reduced EBF, measured as an increase in transendothelial albumin transfer, whereas cholesterol enrichment, like un-enriched LDL, had no effect on EBF. In a second experimental series, rabbits were gavaged with 100 mg of cholesterol or Triol/kg body weight, and LDL was isolated from serum 24 h after gavage. As was seen with the in vitro experiments, Triol-enriched LDL markedly decreased EBF. Similarly, LDL from cholesterol-gavaged rabbits reduced EBF, while LDL from vehicle treated rabbits had no effect. These results suggest that LDL-associated oxysterols are detrimental to normal barrier function of the vascular endothelium. Disruption of this barrier function may serve as an initiating factor in atherosclerotic lesion formation.
Sujet(s)
Cholestérol/métabolisme , Endothélium vasculaire/effets des médicaments et des substances chimiques , Lipoprotéines LDL/pharmacologie , Albumines/métabolisme , Animaux , Cellules cultivées , Cholestérol/analogues et dérivés , Endothélium vasculaire/physiologie , SuidaeRÉSUMÉ
High plasma levels of linoleic acid (18:2) may injure endothelial cells, resulting in decreased barrier function of the vascular endothelium. The effects of linoleic acid on endothelial barrier function (transendothelial movement of albumin), membrane-bound enzyme activities, and possible autooxidation of linoleic acid under experimental conditions were studied. The exposure of endothelial monolayers to 18:2 for 24 hr at 60, 90, and 120 microM fatty acid concentrations caused a significant increase in transendothelial movement of albumin, with maximum albumin transfer at 90 microM. Fatty acid treatment resulted in the increased appearance of cytosolic lipid droplets. Activities of the membrane-bound enzymes, angiotensin-converting enzyme (ACE), and Ca(2+)-ATPase increased steadily with increasing time of cell exposure to 90 microM 18:2, reaching significance at 24 hr. Treatment of endothelial cultures with up to 120 microM 18:2 did not cause cytotoxicity, as evidenced by a nonsignificant change in cellular release of [3H]-adenine. Incubation of 18:2-supplemented serum-containing culture media with 1000 microM 18:2 at 37 degrees C for up to 48 hr did not result in formation of autooxidation products. These results suggest that 18:2 itself, and not its oxidation products, plays a major role in disrupting endothelial barrier function.
Sujet(s)
Endothélium vasculaire/effets des médicaments et des substances chimiques , Acides linoléiques/toxicité , Animaux , Calcium-Transporting ATPases/métabolisme , Perméabilité des membranes cellulaires/effets des médicaments et des substances chimiques , Cellules cultivées , Désoxyribose/métabolisme , Endothélium vasculaire/métabolisme , Endothélium vasculaire/physiologie , Acide linoléique , Métabolisme lipidique , Oxydoréduction , Peroxydes/métabolisme , Sérumalbumine bovine/métabolisme , Suidae , Thiobarbituriques/métabolisme , Facteurs tempsRÉSUMÉ
Experiments were conducted with rats and mice to evaluate the effect of the consumption of endophyte (Acremonium coenophialum) and associated toxin(s) infected tall fescue on humoral and cellular aspects of immune function. Treatment diets were: (1) rodent chow (RC) or (2) rodent chow mixed 1:1 (w/w) with endophyte infected (E+) or (3) non-infected (E-) tall fescue seed. Rats fed the E+ diet in experiment 1 (43 days) exhibited a lower (P less than 0.05) serum titer to sheep red blood cell (SRBC) immunization than those fed the E- diet (38.4 vs 131.3). The E+ rats also had lower (P less than 0.01) white cell counts than either RC or E- groups (5225 vs 8959 and 7491/mm3). Spleen cells from mice fed the E+ diet for 37 days exhibited a reduced (P less than 0.05) response to the mitogens Concanavalin A and lipopolysaccharide. Flow cytometric analysis revealed a significant (P less than 0.01) 42% increase in T suppressor cell numbers in spleens of mice fed the E+ vs RC diets.
Sujet(s)
Acremonium , Immunité , Mycotoxines/intoxication , Intoxication par les plantes , Rate/anatomopathologie , Animaux , Production d'anticorps/immunologie , Poids , Régime alimentaire , Cytométrie en flux/médecine vétérinaire , Tests d'hémagglutination , Immunité cellulaire/immunologie , Numération des leucocytes/médecine vétérinaire , Activation des lymphocytes/immunologie , Mâle , Souris , Souris de lignée C57BL , Mitogènes/pharmacologie , Mycotoxines/administration et posologie , Taille d'organe , Poaceae/microbiologie , Rats , Lignées consanguines de rats , Rate/effets des médicaments et des substances chimiquesRÉSUMÉ
As the endothelium ages it may become more susceptible to damage by atherogenic plasma components such as toxic lipid oxidation products. Vitamin E (vit E) might prove to be anti-atherogenic by reducing oxidative injury. This study investigated the effects of age and chronic exposure to fatty acid hydroperoxides (OFA) and/or vit E on endothelial barrier function (EBF) and cell growth characteristics. Chronic exposure to 5 microM OFA for 40 passages resulted in an age-related decrease in EBF, while supplementation of OFA-treated cultures with 25 microM vit E protected against the OFA-mediated decrease in EBF, independent of cell age. Vit E treatment alone had no significant effect on EBF relative to control cultures. No changes in growth characteristics, i.e., total DNA or protein per culture, were noted, regardless of treatment, although total DNA per culture decreased with increasing culture passage. These results suggest that chronic oxidative stress decreases EBF, predisposing the artery to infiltration by blood components and subsequent atherogenesis and that vit E delays cumulative changes in EBF related to chronic OFA exposure.